Targeting RAS in neuroblastoma: Is it possible?

Abstract excerpt

Neuroblastoma is a common solid tumor in children and a leading cause of cancer death in children. Neuroblastoma exhibits genetic, morphological, and clinical heterogeneity that limits the efficacy of current monotherapies. With further research on neuroblastoma, the pathogenesis of neuroblastoma is found to be complex, and more and more treatment therapies are needed. The importance of personalized therapy is...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Child
• Share to Mutation
• Share to Neoplasm Recurrence, Local